Bicycle Therapeutics: Westfield reports 0 shares
Bicycle Therapeutics plc filed Amendment No. 2 to a Schedule 13G reporting that Westfield Capital Management Company, L.P. beneficially owned 0 shares of Common Stock as of 12/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Bicycle Therapeutics plc filed Amendment No. 2 to a Schedule 13G reporting that Westfield Capital Management Company, L.P. beneficially owned 0 shares of Common Stock as of 12/31/2025. The amendment is signed by Brandi McMahon and dated 03/03/2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Bicycle Therapeutics' Schedule 13G/A filing say about Westfield Capital's holdings (BCYC)?
When is the ownership date reported by Westfield Capital in the BCYC amendment?
Who signed the Schedule 13G/A amendment for Westfield Capital in the BCYC filing?
Does the Schedule 13G/A amendment indicate any voting or dispositive power for Westfield Capital (BCYC)?
What class of securities is covered in the Westfield Capital 13G/A for Bicycle Therapeutics (BCYC)?
AI-generated analysis. How Rhea-AI works. Not financial advice.